← Back to Clinical Trials
Recruiting NCT06892613

NCT06892613 EFCT vs. BCT for Depression and Anxiety in Married Couples

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06892613
Status Recruiting
Phase
Sponsor Beykoz University
Condition Depression Anxiety Disorder
Study Type INTERVENTIONAL
Enrollment 150 participants
Start Date 2025-01-01
Primary Completion 2025-08-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Emotion-Focused Couples Therapy (EFCT)Behavioral Couples Therapy (BCT)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 150 participants in total. It began in 2025-01-01 with a primary completion date of 2025-08-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study compares the effectiveness of Emotion-Focused Couples Therapy (EFCT) and Behavioral Couples Therapy (BCT) in reducing depression and anxiety symptoms in married couples. A total of 150 married couples aged 18-65 will be screened, and 60 couples with high depression and anxiety levels will be selected. These couples will be randomly assigned to one of three groups: EFCT, BCT, or a control group. Therapy sessions will be conducted weekly for 12 weeks, with assessments before therapy, after the 6th and 12th sessions, and at a 3-month follow-up. The study aims to determine which therapy is more effective in improving mental health outcomes in couples.

Eligibility Criteria

Inclusion Criteria: * Married couples aged between 18 and 65 years * Married for at least one year * No current psychiatric diagnosis or history of psychiatric treatment * Not receiving any form of psychological therapy at the time of recruitment * Ability to provide informed consent * Willingness to participate in all therapy sessions and assessments Exclusion Criteria: * Current or past psychiatric diagnosis (excluding mild transient conditions) * Ongoing psychological therapy or psychiatric treatment * Severe mental health disorders (e.g., schizophrenia, bipolar disorder), Substance abuse or dependency * Severe medical conditions that may interfere with participation * Refusal to participate in follow-up assessments

Contact & Investigator

Central Contact

Eda Yılmazer, Phd

✉ edayilmazer@beykoz.edu.tr

📞 +905322575880

Principal Investigator

Eda Yılmazer, Phd

PRINCIPAL INVESTIGATOR

Beykoz University

Frequently Asked Questions

Who can join the NCT06892613 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Depression Anxiety Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06892613 currently recruiting?

Yes, NCT06892613 is actively recruiting participants. Contact the research team at edayilmazer@beykoz.edu.tr for enrollment information.

Where is the NCT06892613 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT06892613 clinical trial?

NCT06892613 is sponsored by Beykoz University. The principal investigator is Eda Yılmazer, Phd at Beykoz University. The trial plans to enroll 150 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology